Severity of nephrotic IgA nephropathy according to the Oxford classification
Tóm tắt
IgA nephropathy with nephrotic syndrome (nephrotic IgAN) is a rare form of IgAN. Its prognosis and response to steroid therapy are still controversial because the differential diagnosis between nephrotic IgAN and minimal change nephrotic syndrome with IgA depositions is sometimes confused. In this retrospective cohort analysis, we accurately diagnosed 42 cases of nephrotic IgAN (4.4%) from 954 IgAN patients, according to the Oxford classification. We analyzed the clinical and histological data, prognosis, and response to steroid therapy. In nephrotic IgAN, mean estimated glomerular filtration rate (eGFR) was 51.1 ± 24.6 ml/min, proteinuria was 5.71 ± 2.56 g/day, and urinary red blood cells were 51.0 ± 37.8 high power field. Both active and chronic histological lesions were observed. Cumulative renal survival rate was significantly lower in nephrotic IgAN than in non-nephrotic IgAN (the control group consisted of 47 non-nephrotic IgAN patients diagnosed between 1995 and 1996) (log-rank test: P < 0.0001). The cases with steroid therapy significantly improved their prognosis, though their male-to-female ratio and blood pressure level measured at renal biopsy were significantly lower than in the cases without steroid therapy. Steroid therapy was particularly effective in cases with low-grade tubular atrophy and interstitial fibrosis (T-grade in Oxford classification). Without steroid therapy, lower eGFR and higher T-grade were independent risk factors for severe outcome by multivariate Cox regression. Nephrotic IgAN is a very severe form of IgAN, with renal dysfunction, massive hematuria, and active and chronic histopathological lesions. Renal outcome is severe; however, steroid therapy can improve prognosis in cases with higher eGFR and lower T-grade, according to the Oxford classification.
Tài liệu tham khảo
Liu XW, Li DM, Xu GS, Sun SR (2010) Comparison of therapeutic effects of leflunomide and mycophenolatemofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome. Int J Clin Pharmacol Ther 48:509–513
Han SH, Kang EW, Park JK, Kie JH, Han DS, Kang SW (2010) Spontaneous remission of nephrotic syndrome in patients with IgA nephropathy. Nephrol Dial Transpl (in press)
Kim SM, Moon KC, Oh SH et al (2009) Clinicopathologic characteristics of IgA nephropathy with steroid-responsive nephrotic syndrome. J Korean Med Sci 24:S44–S49
Rašıć S, Unčanin S, Aganovıč K, Rašıć I, Džemıdžı J, Muslımovıć A (2008) Treatment of IgA nephropathy of adults presented by nephrotic syndrome. Bosn J Basic Med Sci 8:230–233
Maksić D, Marić M, Dimitrijević J et al (1998) Treatment of IgA nephropathy with nephrotic syndrome using pulse doses of IgG. Vojnosanit Pregl 55:79–84
Fukushi K, Yamabe H, Ozawa K et al (1988) Clinico-pathological evaluation of IgA nephropathy associated with nephrotic syndrome. Jpn J Nephrol 30:247–251
Lai KN, Kai FM, Ho CP, Chan W (1986) Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial. Clin Nephrol 26:174–180
Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J (1985) Nephrotic range proteinuria-A good predictive index of disease in IgA nephropathy? Q J Med 57:677–678
Mustonen J, Pasternack P, Rantala I (1983) The nephrotic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin Nephrol 20:172–176
Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y (2003) Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 53:2286–2295
Hwang HS, Kim BS, Shin YS et al (2010) Predictors for progression in immunoglobulin A nephropathy with significant proteinuria. Nephrology 15:236–241
Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM (2002) Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transpl 17:1197–1203
A working group of the international IgA nephropathy network, the renal pathology society (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545
A working group of the international IgA nephropathy network, the renal pathology society (2009) The oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556
Tsukada M, Honda K, Nitta K, Yumura W, Nihei H (2003) Incidental mesangial IgA deposition in minimal change nephrotic syndromes (MCNS). Jpn J Nephrol 45:681–688
Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Al Tieli P, Ponticelli C, Locatelli F (2004) Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 15:157–163
Barratt J, Feehally J (2006) Treatment of IgA nephropathy. Kidney Int 69:1934–1938